Capstan Therapeutics scientists demonstrate that lipid nanoparticles can engineer CAR T cells within the body without laboratory cell manufacturing and ex vivo expansion. The method using targeted lipid nanoparticles (tLNPs) is designed to deliver messenger RNA specifically to CD8+ T cells.
CAR T therapy has revolutionized the treatment of B-cell cancers, with lasting remissions in lupus, myositis, and leukemia and other B-cell–driven autoimmune disorders. The method requires the use of a patient’s own T cells, reengineering those T cells in a lab, growing the population of the modified cells and placing them back in the patient.
More than 20 million U.S. patients living with autoimmune conditions remain without access to the treatment as it depends on costly personalized lab processes, available at only a few specialized centers.
Capstan’s lipid-nanoparticle drug is formulated once, then administered to many patients without tailoring the genetic payload for each recipient, making it a universal option without the specialty center price tag or access obstacles.
In the study, “In vivo CAR T cell generation to treat cancer and autoimmune disease,” published in Science, researchers designed a lipid-nanoparticle delivery system to convert CD8+ T cells inside the body into transient anti-B-cell CAR T cells.
Experiments spanned humanized mice, primary human immune cells, and 22 cynomolgus monkeys given three doses of the therapeutic nanoparticle L829 (0.1–2.0 mg/kg).
A second cohort of 15 monkeys tested a two-dose schedule, and four additional animals examined steroid–antihistamine premedication. Pharmacokinetics, flow cytometry, imaging, and histology tracked CAR expression, B-cell counts, cytokines, and organ distribution.
Bioluminescent and fluorescent reporters confirmed reduced off-target expression in the liver and enhanced accumulation in spleen and lymphoid tissues compared with benchmark lipids used in mRNA vaccines. CD8-L829-tLNPs preferentially modified CD8+ T cells over CD4+ T cells, monocytes, and B cells.
CAR expression was detectable within six hours, declining by 72 hours. CAR T cells engineered in vivo exhibited antigen-specific cytotoxicity, cytokine production, proliferation, and serial killing capacity. Transfected T cells demonstrated effective clearance of CD19+ target cells in vitro.
In humanized mice, a single intravenous dose of 10 or 30 µg CD8-L829-tLNP-CD19 induced near-complete B cell depletion within three hours, with measurable CAR expression on CD8+ T cells persisting at 24 hours.
Nalm6 leukemia-bearing mice receiving the 30 µg dose exhibited near-total tumor clearance in four of five animals within two days of the first dose and complete clearance by the third day after treatment with a second dose.
In cynomolgus monkeys, two or three infusions of CD8-L829-tLNPs encoding an anti-CD20 CAR at 0.1 to 2.0 mg/kg resulted in rapid and profound B cell depletion across blood, spleen, and lymph nodes. CAR expression was observed in up to 85% of CD8+ T cells and 95% of CD8+ NK cells, with minimal expression in CD4+ populations. B cell repopulation began by day 21 and was characterized by a predominantly naive phenotype.
Mild and transient elevations in liver enzymes and pro-inflammatory cytokines, including interleukin-6 and interferon-gamma, were recorded at higher doses. One animal in the 1.5 mg/kg group was euthanized due to clinical features consistent with immune effector cell-associated hemophagocytic lymphohistiocytosis. A compact two-dose regimen replicated depletion efficacy while reducing cytokine release.
Targeted lipid nanoparticles enable in vivo generation of functional CAR T cells without requiring ex vivo cell manipulation or integrating viral vectors.
Researchers at Capstan Therapeutics demonstrated that lipid nanoparticle formulations bearing mRNA and conjugated to CD8-targeting antibodies can program T cells directly inside the body, offering a platform that bypasses conventional manufacturing, lymphodepletion, and the costly infrastructure required for existing CAR T therapies.
As lipid nanoparticle therapeutics are commercially scalable and already validated in mRNA vaccines, this technology may represent a foundational shift toward broader clinical use of engineered immunotherapy from within the patient’s body.
Written for you by our author Justin Jackson, edited by Sadie Harley, and fact-checked and reviewed by Robert Egan—this article is the result of careful human work. We rely on readers like you to keep independent science journalism alive. If this reporting matters to you, please consider a donation (especially monthly). You’ll get an ad-free account as a thank-you.
News
Nanomedicine in 2026: Experts Predict the Year Ahead
Progress in nanomedicine is almost as fast as the science is small. Over the last year, we've seen an abundance of headlines covering medical R&D at the nanoscale: polymer-coated nanoparticles targeting ovarian cancer, Albumin recruiting nanoparticles for [...]
Lipid nanoparticles could unlock access for millions of autoimmune patients
Capstan Therapeutics scientists demonstrate that lipid nanoparticles can engineer CAR T cells within the body without laboratory cell manufacturing and ex vivo expansion. The method using targeted lipid nanoparticles (tLNPs) is designed to deliver [...]
The Brain’s Strange Way of Computing Could Explain Consciousness
Consciousness may emerge not from code, but from the way living brains physically compute. Discussions about consciousness often stall between two deeply rooted viewpoints. One is computational functionalism, which holds that cognition can be [...]
First breathing ‘lung-on-chip’ developed using genetically identical cells
Researchers at the Francis Crick Institute and AlveoliX have developed the first human lung-on-chip model using stem cells taken from only one person. These chips simulate breathing motions and lung disease in an individual, [...]
Cell Membranes May Act Like Tiny Power Generators
Living cells may generate electricity through the natural motion of their membranes. These fast electrical signals could play a role in how cells communicate and sense their surroundings. Scientists have proposed a new theoretical [...]
This Viral RNA Structure Could Lead to a Universal Antiviral Drug
Researchers identify a shared RNA-protein interaction that could lead to broad-spectrum antiviral treatments for enteroviruses. A new study from the University of Maryland, Baltimore County (UMBC), published in Nature Communications, explains how enteroviruses begin reproducing [...]
New study suggests a way to rejuvenate the immune system
Stimulating the liver to produce some of the signals of the thymus can reverse age-related declines in T-cell populations and enhance response to vaccination. As people age, their immune system function declines. T cell [...]
Nerve Damage Can Disrupt Immunity Across the Entire Body
A single nerve injury can quietly reshape the immune system across the entire body. Preclinical research from McGill University suggests that nerve injuries may lead to long-lasting changes in the immune system, and these [...]
Fake Science Is Growing Faster Than Legitimate Research, New Study Warns
New research reveals organized networks linking paper mills, intermediaries, and compromised academic journals Organized scientific fraud is becoming increasingly common, ranging from fabricated research to the buying and selling of authorship and citations, according [...]
Scientists Unlock a New Way to Hear the Brain’s Hidden Language
Scientists can finally hear the brain’s quietest messages—unlocking the hidden code behind how neurons think, decide, and remember. Scientists have created a new protein that can capture the incoming chemical signals received by brain [...]
Does being infected or vaccinated first influence COVID-19 immunity?
A new study analyzing the immune response to COVID-19 in a Catalan cohort of health workers sheds light on an important question: does it matter whether a person was first infected or first vaccinated? [...]
We May Never Know if AI Is Conscious, Says Cambridge Philosopher
As claims about conscious AI grow louder, a Cambridge philosopher argues that we lack the evidence to know whether machines can truly be conscious, let alone morally significant. A philosopher at the University of [...]
AI Helped Scientists Stop a Virus With One Tiny Change
Using AI, researchers identified one tiny molecular interaction that viruses need to infect cells. Disrupting it stopped the virus before infection could begin. Washington State University scientists have uncovered a method to interfere with a key [...]
Deadly Hospital Fungus May Finally Have a Weakness
A deadly, drug-resistant hospital fungus may finally have a weakness—and scientists think they’ve found it. Researchers have identified a genetic process that could open the door to new treatments for a dangerous fungal infection [...]
Fever-Proof Bird Flu Variant Could Fuel the Next Pandemic
Bird flu viruses present a significant risk to humans because they can continue replicating at temperatures higher than a typical fever. Fever is one of the body’s main tools for slowing or stopping viral [...]
What could the future of nanoscience look like?
Society has a lot to thank for nanoscience. From improved health monitoring to reducing the size of electronics, scientists’ ability to delve deeper and better understand chemistry at the nanoscale has opened up numerous [...]
